Hawaii Biotech Awarded $38.5 Million for Continued Development of Anti‐toxin Drug to Treat Anthrax in Humans
Soligenix Announces Presentation of Positive Preliminary Results of a Heat Stable Formulation of Hawaii Biotech Ebola Vaccine
Hirono, Ige, Public Health, and Emergency Response Experts Raise Awareness, Call for Funding to Fight Zika